Pancreatitis: Acute pancreatitis is thought to be a threat variable for GLP-1 medicine. Tirzepatide has a comparable amount of hazard as GLP-1 agonist medicines. If a affected individual receiving tirzepatide therapy encounters major abdominal pain, they need to be urged to visit their community cri